Ambisafe, an Ethereum asset management platform has just announced its newest development — Orderbook, a trading platform for Ethereum-based ICO tokens.
Ambisafe has helped to launch successful ICOs for several blockchain companies, particularly Polybius, TaaS, and Chronobank. The Polybius ICO has so far raised over $21.2 million dollars, whilst the TaaS ICO has raised over $7.5 million dollars with over 3,900 investors.
Orderbook, a new venture organized by the team behind Ambisafe, is a trading platform for Ethereum-based ICO tokens. Through this trading platform, ICO participants can take advantage of cutting edge security, in which all critical operations are executed via Ethereum smart contracts, and all assets will be held “on-chain.”
All asset information will be available on the platform including dividend history, trading protocols, transaction volumes and analytics from trusted cryptocurrency sources.
Furthermore, The Orderbook exchange platform will streamline operations and ensure transparency for both ICO founders and traders. Since the platform is implemented as a set of smart contracts, all trade history will be available for audit to ensure that there are no fraudulent manipulations. The unique trading interface will contain additional information about companies and provide the ability to receive dividends directly for traders, thus creating an efficient, transparent and versatile environment for the cryptocurrency industry.
To learn more about Orderbook:
● Website: https://orderbook.io
● Facebook: https://www.facebook.com/orderbookio
● Twitter: https://twitter.com/orderbook_io
● Telegram: https://t.me/joinchat/AAAAAA2i5AUMn3RpatYG5Q
Please note that Orderbook will be launched as alpha version which may include minor bugs and non-critical issues.
Media Contact: email@example.com
Ambisafe is the source of this content. Virtual currency is not legal tender, is not backed by the government, and accounts and value balances are not subject to FDIC and other consumer protections. This press release is for informational purposes only. The information does not constitute investment advice or an offer to invest.